The FDA approved, ultra-low-cost ESM-UBT device has been demonstrated to save nearly every hemorrhaging woman if the device is readily available in a timely fashion.
Our long-term business model is to facilitate and approve the launch of successful regional businesses on assembly and distribution of quality ESM-UBT devices. ESM-UBT has the potential to have a large, global impact while also serving as a disruptive solution to drive down the cost of PPH treatment everywhere.
